47
GT Biopharma, Inc. raises $7.8M under Reg D
Company raise · Raising · Offering $39M · Sold $7.8M · SAN FRANCISCO, CA · filed 2026-09-29
47
GT Biopharma, Inc. raises $20M under Reg D
Company raise · Pre-first close · SAN FRANCISCO, CA · Form D filed 2025-05-28
$10M+ raise
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Michael Breen | Chief Executive Officer |
| Alan Urban | Chief Financial Officer |
| Hilary Kramer | Director |
| Charles Casamento | Director |
| Andrew Ritter | Director |
Signed by Alan Urban, Chief Financial Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
40
GT Biopharma, Inc. raises $6M under Reg D
Company raise · Closed · Offering $6M · Sold $6M · SAN FRANCISCO, CA · filed 2025-05-27
45
GT Biopharma, Inc. raises $1.3M under Reg D
Company raise · Closed · Offering $1.3M · Sold $1.3M · SAN FRANCISCO, CA · filed 2025-03-07
Placement agent engaged